Research area is an excellent fit—Eniola's CCT model, computational methods, and neuropharmacology align perfectly with Harvard's program including computational neuroscience electives. However, there is significant career-stage mismatch: applicant is currently seeking MSc enrollment (Oct 2026 in Austria) and explicitly targets fellowships, grants, and training, not PhD programs at this stage.